Skip links
Let's Talk
Emulent Marketing

Biopharma Marketing Services That Build Authority and Generate Pipeline

Our biopharma marketing agency supports emerging biopharma companies, biologics manufacturers, and biosimilar brands in building market visibility using compliant digital marketing tailored to the unique requirements of biological products.

Learn More
Contact Us
Pharmaceutical Brands 1@3X 100 Emulent
Emulent Marketing Proejct Reprocell E1722360186544 Emulent
Agno Emulent
Emulent Marketing Proejct Lubrizol Emulent
Emulent Marketing Proejct Altus Medical Equipment Emulent
Emulent Marketing Proejct Camargo Project Emulent
Premier Research Emulent

Our biopharma marketing agency takes a unique approach to helping biologics and biosimilar companies build prescriber confidence, educate patients on complex therapies, and compete in a market defined by scientific credibility and regulatory compliance.

Marketing Challenges We Address for Biopharma Brands

Biopharma companies face unique challenges at the intersection of pharmaceutical regulation and biological science. Whether you are preparing to launch your first biologic, competing as a biosimilar manufacturer, or expanding your prescriber base, we help address the following challenges:

  • Prescribers do not fully understand our complex biologic product.
  • We need to overcome prescriber hesitation when launching a biosimilar.
  • As an emerging biopharma company, we lack brand recognition.
  • Our patients face challenges with access and affordability.
  • We need to engage payers and formulary decision-makers.
  • Our digital marketing efforts are not generating qualified HCP leads.
  • We are preparing for a commercial product launch and require strategic support.
  • We require real-world evidence to support our marketing claims.
Pharmaceutical Brands_3@3X-100
Agno Emulent

Building a Unified Brand Identity for a Global Pharmaceutical CDMO After Acquisition

Agno Pharma is a global company that offers contract development and manufacturing services for the pharmaceutical industry.

Industry: Pharmaceutical / CDMO

Type: Global Enterprise

Challenge: Agno Pharma was acquiring a US-based CDMO and needed a brand refresh to represent the new, combined company.
They needed a full range of services, including website design, branding, logo design, SEO, and content creation, to build their new identity and support growth.

Approach: We delivered complete marketing support and strategy, including:

  • Designing and developing their website
  • Creating a new logo and brand identity that reflected the strengths of both companies
  • Implementing SEO to help the new brand rank for competitive keywords in the CDMO industry
  • Developing content to position them as industry leaders and attract pharmaceutical companies looking for manufacturing partners
  • We continue to offer strategic support and guidance as a trusted advisor for their brand.

We are incredibly grateful for Bill and his team. Their expertise has been instrumental in our growth, from designing our website and logo to optimizing our SEO, creating compelling blog content, and offering great ideas.

Bill’s responsiveness and professionalism have made him a trusted partner for over three major website updates. He takes the time to truly understand our brand, ensuring that every project reflects our vision. We would not go anywhere else – if you’re looking for a dedicated team to assist with multiple aspects of your business, Bill and Emulent are the experts to work with!

Ingrid Schaper

Marketing Lead, Agno Pharma

30%+
SQLs
222%+
Organic Traffic
View More Client Stories

Biopharma SEO & Organic Search

Organic search is a key research channel for HCPs evaluating biologic therapies and for patients seeking treatment information. We develop SEO programs that target therapeutic area keywords, product comparisons, and disease-state queries, while adhering to Google’s quality standards for medical content.

  • Therapeutic area SEO: Target keywords related to specific disease states, treatment protocols, and clinical decision points where prescribers and patients seek biologic therapy information.
  • Biosimilar comparison SEO: Develop content that addresses reference biologic versus biosimilar comparisons, interchangeability searches, and questions about switching therapies.
  • Technical SEO: Optimize site architecture for multi-product portfolios, implement schema markup for drug products and clinical data, and ensure mobile responsiveness and strong Core Web Vitals.
  • AI search visibility: Position content for discovery through ChatGPT, Perplexity, and Google AI Overviews, as HCPs and patients increasingly use these platforms to find therapy information.
Pharmaceutical Brands Services Emulent
Pharmaceutical Brands Services Emulent

Biopharma Website Design & Development

Your online presence shapes perceptions among investors, partners, regulatory agencies, job candidates, and customers. We design biotech websites that address the needs of these audiences while maintaining scientific accuracy and professionalism.

  • Pipeline and product pages present development stages, target indications, mechanisms of action, and clinical data in a clear format for investors and partners.
  • Our multi-audience architecture provides dedicated content pathways for researchers, investors, healthcare professionals, patients, and partners, with navigation tailored to each group’s priorities.
  • We deliver CMS and technical development using WordPress, HubSpot, or custom solutions. Our services include content management workflows for regulated materials, contact capture, investor inquiry pathways, and calls-to-action tailored to B2B biotech sales cycles.

Prescriber Education & HCP Marketing

Prescribers are the primary decision-makers for biologic therapies. We engage physicians, specialists, and other HCPs through targeted digital campaigns that deliver clinical evidence and educational content to support confident prescribing.

  • Clinical education content includes mechanism-of-action materials, clinical trial summaries, real-world evidence presentations, and treatment protocol guides.
  • Omnichannel HCP engagement features programmatic advertising by specialty, clinical update email campaigns, LinkedIn targeting, and webinar programs.
  • Biosimilar prescriber programs offer switching study data, interchangeability education, formulary transition guides, and FAQ resources specifically designed to address prescriber concerns about biosimilar products.
  • KOL engagement programs connect your brand with respected specialists who can amplify your clinical messaging within their professional networks.
Pharmaceutical Brands Services Emulent
Pharmaceutical Brands Services Emulent

Patient Marketing & Access Programs

Biologic therapies are among the most expensive medications. Effective patient marketing in biopharma should go beyond raising awareness to help patients understand how to access and afford their treatment.

  • Disease awareness campaigns: Offer unbranded educational content about conditions treated by your biologic to encourage patients to discuss diagnosis and treatment options with their physicians.
  • Patient access content: Provide clear information about insurance coverage, prior authorization, specialty pharmacy enrollment, and patient assistance programs.
  • Cost and affordability messaging: Share content that communicates biosimilar savings, copay assistance programs, and available financial support resources.
  • Compliance-first approach: Ensure all patient content includes fair balance, risk disclosure, and ISI as required by FDA regulations.

PPC & Paid Media for Biopharma

Paid advertising increases visibility during product launches, formulary decisions, and competitive periods. We deliver compliant campaigns across search, social, and programmatic channels to reach both HCPs and patients.

  • Search advertising: Google Ads targeting condition-specific, treatment comparison, and product-specific keywords, using compliance-reviewed ad copy.
  • Programmatic HCP targeting: Display ads on medical publications and clinical platforms, segmented by specialty and prescribing behavior.
  • LinkedIn campaigns: B2B ads targeting healthcare executives, medical directors, and formulary decision-makers.
  • Patient audience targeting: Compliant social media and display campaigns reaching patients researching specific conditions and treatments.
Pharmaceutical Brands Services Emulent

Biopharma Marketing Statistics

  1. The global biosimilars market is projected to reach $100 billion by 2030.
  2. Biologic drugs account for over 40% of total U.S. prescription drug spending.
  3. Biosimilars can reduce costs by 15-40% compared to reference biologics.
  4. 71% of HCPs prefer digital interactions when learning about new therapies.
  5. Personalized HCP content increases engagement by 56% compared to generic messaging.
  6. Disease awareness campaigns improve patient-physician conversations by 28%.
  7. Specialty pharmacy utilization for biologics has grown 12% year-over-year.
  8. Multichannel biopharma campaigns see 43% higher HCP engagement rates.
  9. Real-world evidence content generates 2x more prescriber engagement than promotional content alone.
  10. Patient assistance program awareness campaigns improve therapy access by 25%.
  11. Digital channels now account for over 70% of healthcare advertising spend.
  12. Biopharma companies that publish educational content see 3x more website engagement.
  13. Email marketing to HCPs delivers an average 38% open rate when targeted by specialty.
  14. Formulary-focused marketing materials improve payer decision timelines by 20%.

Sources: IQVIA, McKinsey, MM+M, FDA, Statista

Pharmaceutical Brands Services Emulent
Faqs Emulent Emulent

Biopharma Digital Marketing FAQs

Can you help with biosimilar launch marketing?

Yes. Biosimilar launches require targeted strategies, including prescriber education, formulary positioning, patient access messaging, and differentiation from the reference biologic. We develop launch campaigns that address each area through coordinated digital channels.

Do you work with emerging biopharma companies that do not have commercial products yet?

Yes. We support pre-commercial biopharma companies by building investor-ready digital presences, developing pipeline communication, and establishing a strong brand foundation for future commercial launches.

How do you handle the compliance requirements for biologic product marketing?

We develop all content with regulatory review in mind. Our process includes compliance checkpoints at each stage and coordination with your MLR team to ensure all claims are supported by approved data. We are experienced with FDA fair balance requirements, ISI presentation, and the rules for both branded and unbranded biologic promotion.

Can you support both HCP and patient marketing?

Yes. We create integrated programs for both HCPs and patients, including clinical education, prescriber targeting, KOL initiatives, disease awareness, access information, and affordability content. These efforts are coordinated to ensure a consistent brand experience.